Peter Harrison

801 total citations · 1 hit paper
19 papers, 342 citations indexed

About

Peter Harrison is a scholar working on Physiology, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Peter Harrison has authored 19 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Physiology, 5 papers in Psychiatry and Mental health and 4 papers in Molecular Biology. Recurrent topics in Peter Harrison's work include Alzheimer's disease research and treatments (7 papers), Dementia and Cognitive Impairment Research (5 papers) and Cerebrospinal fluid and hydrocephalus (2 papers). Peter Harrison is often cited by papers focused on Alzheimer's disease research and treatments (7 papers), Dementia and Cognitive Impairment Research (5 papers) and Cerebrospinal fluid and hydrocephalus (2 papers). Peter Harrison collaborates with scholars based in United Kingdom, Sweden and United States. Peter Harrison's co-authors include Kaj Blennow, Fernando González‐Ortiz, Przemysław R. Kac, Michael Turton, Thomas K. Karikari, Henrik Zetterberg, B. Ollivere, B. J. O’Reilly, Nicholas J. Ashton and Enrico Premi and has published in prestigious journals such as Brain, Neurology and Kidney International.

In The Last Decade

Peter Harrison

17 papers receiving 330 citations

Hit Papers

Brain-derived tau: a novel blood-based biomarker for Alzh... 2022 2026 2023 2024 2022 40 80 120
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Brain-derived tau: a novel blood-based biomarker for Alzheimer’s disease-type neurodegeneration
    2022 134 citations Fernando González‐Ortiz, Michael Turton et al. Brain profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Harrison United Kingdom 9 144 88 67 56 49 19 342
Nobukazu Tanaka Japan 9 56 0.4× 74 0.8× 31 0.5× 68 1.2× 14 0.3× 28 297
Antonio José Cañada Martínez Spain 12 53 0.4× 90 1.0× 26 0.4× 81 1.4× 34 0.7× 51 400
Nesrine A Mohamed Egypt 11 85 0.6× 30 0.3× 8 0.1× 20 0.4× 37 0.8× 36 339
Fotios Koskeridis Greece 9 49 0.3× 65 0.7× 15 0.2× 20 0.4× 10 0.2× 13 348
Wei-Hsi Chen Taiwan 10 43 0.3× 46 0.5× 68 1.0× 32 0.6× 79 1.6× 49 373
Sena Ulu Türkiye 10 126 0.9× 41 0.5× 21 0.3× 31 0.6× 19 0.4× 25 403
Irina Lisinen Finland 11 142 1.0× 35 0.4× 23 0.3× 127 2.3× 11 0.2× 12 557
A. H. Zwinderman Netherlands 13 236 1.6× 39 0.4× 25 0.4× 196 3.5× 34 0.7× 16 577
Jong Seung Kim South Korea 11 57 0.4× 21 0.2× 19 0.3× 84 1.5× 106 2.2× 42 502
Susumu Fujioka Japan 9 139 1.0× 52 0.6× 18 0.3× 132 2.4× 17 0.3× 30 424

Countries citing papers authored by Peter Harrison

Since Specialization
Citations

This map shows the geographic impact of Peter Harrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Harrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Harrison more than expected).

Fields of papers citing papers by Peter Harrison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Harrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Harrison. The network helps show where Peter Harrison may publish in the future.

Co-authorship network of co-authors of Peter Harrison

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Harrison. A scholar is included among the top collaborators of Peter Harrison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Harrison. Peter Harrison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
González‐Ortiz, Fernando, Bjørn‐Eivind Kirsebom, Lene Pålhaugen, et al.. (2025). Associations Between Changes in Levels of Phosphorylated Tau and Severity of Cognitive Impairment in Early Alzheimer Disease. Neurology. 104(11). e213676–e213676. 3 indexed citations
2.
Dulewicz, Maciej, Przemysław R. Kac, Fernando C. Ortíz, et al.. (2025). Clinical Validation of Novel Immunoassays for Plasma Phosphorylated Tau 217, 212, 181, 231, and Brain‐Derived Tau Across the Biochemical Spectrum of Alzheimer's Disease. Journal of Neurochemistry. 169(12). e70313–e70313.
3.
Kirsebom, Bjørn‐Eivind, Fernando González‐Ortiz, Geir Bråthen, et al.. (2025). Repeated plasma p‐tau217 measurements to monitor clinical progression heterogeneity. Alzheimer s & Dementia. 21(5). e70319–e70319. 3 indexed citations
4.
Kac, Przemysław R., Daniel Alcolea, Laia Montoliu‐Gaya, et al.. (2025). Plasma p‐tau212 as a biomarker of sporadic and Down syndrome Alzheimer's disease. Alzheimer s & Dementia. 21(4). e70172–e70172. 3 indexed citations
5.
González‐Ortiz, Fernando, Bjørn‐Eivind Kirsebom, Ulrika Sjöbom, et al.. (2025). The potential dual role of tau phosphorylation: plasma phosphorylated-tau217 in newborns and Alzheimer’s disease. Brain Communications. 7(3). fcaf221–fcaf221. 4 indexed citations
6.
González‐Ortiz, Fernando, Michael Turton, Henrik Zetterberg, et al.. (2025). Brain‐derived tau to measure treatment effect in Alzheimer's disease and frontotemporal dementia. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 17(2). e70123–e70123.
7.
González‐Ortiz, Fernando, Michael Turton, Rui Magalhães, et al.. (2023). Preanalytical stability of plasma/serum brain‐derived tau. Alzheimer s & Dementia. 19(10). 4764–4770. 9 indexed citations
8.
González‐Ortiz, Fernando, Maciej Dulewicz, Nicholas J. Ashton, et al.. (2023). Association of Serum Brain-Derived Tau With Clinical Outcome and Longitudinal Change in Patients With Severe Traumatic Brain Injury. JAMA Network Open. 6(7). e2321554–e2321554. 16 indexed citations
9.
González‐Ortiz, Fernando, Thomas K. Karikari, Simone Baiardi, et al.. (2023). Levels of plasma brain‐derived tau and p‐tau181 in Alzheimer's disease and rapidly progressive dementias. Alzheimer s & Dementia. 20(1). 745–751. 11 indexed citations
10.
González‐Ortiz, Fernando, Michael Turton, Przemysław R. Kac, et al.. (2022). Brain-derived tau: a novel blood-based biomarker for Alzheimer’s disease-type neurodegeneration. Brain. 146(3). 1152–1165. 134 indexed citations breakdown →
11.
Mukherjee, Jean, et al.. (2012). Sheep Monoclonal Antibodies Prevent Systemic Effects of Botulinum Neurotoxin A1. Toxins. 4(12). 1565–1581. 8 indexed citations
12.
Ollivere, B., et al.. (2005). Swallowing dysfunction in patients with unilateral vocal fold paralysis: aetiology and outcomes. The Journal of Laryngology & Otology. 120(1). 38–41. 44 indexed citations
13.
Persad, Raj, David Gillatt, Peter Harrison, & Paul Abrams. (1992). Dialysis in Patients with Upper Urinary Tract Transitional Cell Carcinoma. British Journal of Urology. 69(6). 577–579. 7 indexed citations
14.
Wong, Rodney & Peter Harrison. (1992). NonEBV-related B-cell lymphoma in a renal transplant patient responding to acyclovir and reduction in immunosuppression. Postgraduate Medical Journal. 68(796). 145–146. 1 indexed citations
15.
Savage, Caroline O. S., Charles D. Pusey, Michael J. Kershaw, et al.. (1986). The Goodpasture antigen in Alport's syndrome: Studies with a monoclonal antibody. Kidney International. 30(1). 107–112. 59 indexed citations
16.
Browning, Michael J., et al.. (1984). Continuous Ambulatory Peritoneal Dialysis in Systemic Amyloidosis and End-Stage Renal Disease. Journal of the Royal Society of Medicine. 77(3). 189–192. 17 indexed citations
17.
Browning, Michael J., R. A. Banks, C R Tribe, et al.. (1983). Renal involvement in systemic amyloidosis.. PubMed. 20. 595–602. 10 indexed citations
18.
Harrison, Peter & S. A. Feldman. (1981). Intubating conditions with ORG NC45. Anaesthesia. 36(9). 874–877. 11 indexed citations
19.
Harrison, Peter, et al.. (1969). Experimental study on intravascular fat. The American Journal of Surgery. 117(4). 595–598. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nobukazu Tanaka Breakdown of academic impact, for papers by Antonio José Cañada Martínez Breakdown of academic impact, for papers by Nesrine A Mohamed Breakdown of academic impact, for papers by Fotios Koskeridis Breakdown of academic impact, for papers by Wei-Hsi Chen Breakdown of academic impact, for papers by Sena Ulu Breakdown of academic impact, for papers by Irina Lisinen Breakdown of academic impact, for papers by A. H. Zwinderman Breakdown of academic impact, for papers by Jong Seung Kim Breakdown of academic impact, for papers by Susumu Fujioka
Rankless by CCL
2026